ATC Group: N02BF02 Pregabalin

The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.

Position of N02BF02 in the ATC hierarchy

Level Code Title
1 N Nervous system
2 N02 Analgesics
3 N02B Other analgesics and antipyretics
4 N02BF Gabapentinoids
5 N02BF02 Pregabalin

Defined daily dose

The DDD is the assumed average maintenance dose per day for a drug used for its main indication in adults. The DDD is a unit of measurement and does not necessarily reflect the recommended or Prescribed Daily Dose. Therapeutic doses for individual patients and patient groups will often differ from the DDD as they will be based on individual characteristics (such as age, weight, ethnic differences, type and severity of disease) and pharmacokinetic considerations.

Route Amount
ORAL - Oral 0.3 g

Active ingredients in N02BF02

Active Ingredient Description
Pregabalin

Pregabalin binds to an auxiliary subunit (α2-δ protein) of voltage-gated calcium channels in the central nervous system.

Related product monographs

Title Information Source Document Type  
EPIBAL Hard capsule Υπουργείο Υγείας (CY) MPI, EU: SmPC
LYRICA Hard capsule European Medicines Agency (EU) MPI, EU: SmPC
NUBACAP Hard gelatine capsule Health Products Regulatory Authority (ZA) MPI, Generic
NURIKA Hard capsule Health Products Regulatory Authority (ZA) MPI, Generic
REGADEX Hard capsule Health Sciences Authority (SG) MPI, Generic
TIMIRIL Capsule Health Products Regulatory Authority (ZA) MPI, Generic

Medicines in this ATC group

United States (US)

Albania (AL)

Canada (CA)

Finland (FI)

France (FR)

Ireland (IE)

Israel (IL)

Japan (JP)

Mexico (MX)

Netherlands (NL)

New Zealand (NZ)

Romania (RO)

United Kingdom (UK)

Note the following: The list of brand names is continuously updated, and thus does not include the total of products circulating worldwide.